Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197


MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.

Zhou J, Liu R, Luo C, Zhou X, Xia K, Chen X, Zhou M, Zou Q, Cao P, Cao K.

Cancer Biol Ther. 2014 Oct;15(10):1340-9. doi: 10.4161/cbt.29821. Epub 2014 Jul 14.


Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.

Zhang L, Xiang P, Han X, Wu L, Li X, Xiong Z.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11446-51. eCollection 2015.


MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.

Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E, Pivarcsi A.

J Biol Chem. 2012 Aug 24;287(35):29899-908. doi: 10.1074/jbc.M112.391243. Epub 2012 Jul 10.


MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.

Xiong Y, Zhang L, Kebebew E.

PLoS One. 2014 May 23;9(5):e96103. doi: 10.1371/journal.pone.0096103. eCollection 2014.


MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.

Tan Y, Hu H, Tan W, Jin L, Liu J, Zhou H.

Mol Med Rep. 2016 Nov;14(5):4422-4428. doi: 10.3892/mmr.2016.5769. Epub 2016 Sep 23.


miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.

Xia H, Sun S, Wang B, Wang T, Liang C, Li G, Huang C, Qi D, Chu X.

Int J Mol Sci. 2014 Jul 7;15(7):11973-83. doi: 10.3390/ijms150711973.


Identification of FLOT2 as a novel target for microRNA-34a in melanoma.

Liu R, Xie H, Luo C, Chen Z, Zhou X, Xia K, Chen X, Zhou M, Cao P, Cao K, Zhou J.

J Cancer Res Clin Oncol. 2015 Jun;141(6):993-1006. doi: 10.1007/s00432-014-1874-1. Epub 2014 Nov 18.


Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling.

Chen P, Zeng M, Zhao Y, Fang X.

Oncol Rep. 2014 Nov;32(5):2070-6. doi: 10.3892/or.2014.3461. Epub 2014 Sep 2.


MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.

Olasz EB, Seline LN, Schock AM, Duncan NE, Lopez A, Lazar J, Flister MJ, Lu Y, Liu P, Sokumbi O, Harwood CA, Proby CM, Neuburg M, Lazarova Z.

PLoS One. 2015 May 4;10(5):e0125412. doi: 10.1371/journal.pone.0125412. eCollection 2015.


MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.

Chen B, Pan W, Lin X, Hu Z, Jin Y, Chen H, Ma G, Qiu Y, Chang L, Hua C, Zou Y, Gao Y, Ying H, Lv D.

Tumour Biol. 2016 Feb;37(2):2765-71. doi: 10.1007/s13277-015-4046-2. Epub 2015 Sep 26.


HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.

Hu J, Ge W, Xu J.

Tumour Biol. 2016 Jul;37(7):9433-40. doi: 10.1007/s13277-016-4817-4. Epub 2016 Jan 19.


MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.

Wang SH, Zhou JD, He QY, Yin ZQ, Cao K, Luo CQ.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):7131-41. eCollection 2014.


MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1.

Lin N, Zhou Y, Lian X, Tu Y.

Oncol Lett. 2017 Mar;13(3):1078-1082. doi: 10.3892/ol.2017.5554. Epub 2017 Jan 2.


Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.

Luo Q, Li W, Zhao T, Tian X, Liu Y, Zhang X.

Arch Biochem Biophys. 2015 Oct 1;583:47-54. doi: 10.1016/ Epub 2015 Aug 5.


MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.

Wang A, Landén NX, Meisgen F, Lohcharoenkal W, Ståhle M, Sonkoly E, Pivarcsi A.

PLoS One. 2014 Jul 28;9(7):e103206. doi: 10.1371/journal.pone.0103206. eCollection 2014.


Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.

Cao J, Zhang C, Chen T, Tian R, Sun S, Yu X, Xiao C, Wang G, Liu Y, Fu M, Li W.

J Dermatol Sci. 2015 Aug;79(2):127-36. doi: 10.1016/j.jdermsci.2015.05.002. Epub 2015 May 15.


miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).

Zhou M, Zhou L, Zheng L, Guo L, Wang Y, Liu H, Ou C, Ding Z.

PLoS One. 2014 Jun 20;9(6):e100620. doi: 10.1371/journal.pone.0100620. eCollection 2014.


MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.

Lohcharoenkal W, Harada M, Lovén J, Meisgen F, Landén NX, Zhang L, Lapins J, Mahapatra KD, Shi H, Nissinen L, Kähäri VM, Ståhle M, Sonkoly E, Grandér D, Arsenian-Henriksson M, Pivarcsi A.

J Invest Dermatol. 2016 Dec;136(12):2485-2494. doi: 10.1016/j.jid.2016.06.630. Epub 2016 Jul 22.


miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14.

Jia LF, Wei SB, Mitchelson K, Gao Y, Zheng YF, Meng Z, Gan YH, Yu GY.

PLoS One. 2014 Sep 30;9(9):e108435. doi: 10.1371/journal.pone.0108435. eCollection 2014.


miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.

Du Y, Li Y, Lv H, Zhou S, Sun Z, Wang M.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12252-9. eCollection 2015.

Supplemental Content

Support Center